Compare Applied Materials, Inc. (AMAT) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Applied Materials, Inc. vs BIO-TECHNE Corp — how do they compare? Applied Materials, Inc. trades at $527.19 (market cap $414.54B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: Applied Materials, Inc. is far larger — about 36.9× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays the higher dividend (0.44%). Which is the better fit depends on your goals.
| AMAT | TECH | |
|---|---|---|
Market Cap | $414.54B | $11.24B |
Sector | Technology | Health |
52-Week High | $723.00 | $72.29 |
52-Week Low | $156.25 | $43.31 |
Enterprise Value | $413.57B | $11.32B |
Dividend Yield | 0.41% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Applied Materials (AMAT) trades at $539.14, up 2.21% today, showing strong momentum amid bullish technical signals and consistent earnings beats. The stock benefits from robust fundamentals including 29.31% net margins and 39.69% ROE, with revenue growth projected to reach $29B in 2026. Recent news highlights CEO Gary Dickerson's optimistic outlook on AI-driven semiconductor demand, calling this 'the greatest time in the history of our industry' (CNBC, 2026-05-28).
Outlook remains positive with 76.9% analyst buy ratings and $662.82 consensus target, though elevated P/E of 50.72 poses valuation risk. Key opportunities include AI infrastructure expansion and strong operating leverage, while risks involve semiconductor cycle volatility and competitive pressures in chip equipment markets.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applied Materials, Inc.
Applied Materials is the world's largest supplier of semiconductor manufacturing equipment, providing materials engineering solutions to help make nearly every chip in the world. The firm's systems are used in nearly every major process step with the exception of lithography. Key tools include those for chemical and physical vapor deposition, etching, chemical mechanical polishing, wafer- and reticle-inspection, critical dimension measurement, and defect-inspection scanning electron microscopes.
Read more on AMAT →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
